Skip to content

Nudging Provider Adoption of Clinical Decision Support

Nudging Provider Adoption of Clinical Decision Support

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05203185
Enrollment
1612
Registered
2022-01-24
Start date
2021-07-01
Completion date
2022-04-30
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Embolism

Keywords

Clinical Decision Support, Pulmonary Embolism, Behavioral Design, Health Informatics

Brief summary

The central hypothesis of this proposal is that the addition of a theory-informed nudge to a clinical decision support (CDS) tool will address identified behavioral barriers to use and significantly improve adoption by providers. Nudges are applications of behavioral science, defined as positive reinforcement and indirect suggestions that have a non-forced effect on decision making. This study will use a behavioral theory-informed process to develop a new CDS tool that includes a nudge that addresses barriers to adoption.

Detailed description

The research team developed and pilot tested two CDS tools for pulmonary embolism (PE) risk stratification in the Emergency Department (ED). One of the tools incorporated two behavioral theory-informed nudges in the user interface. The research team's objective was to pilot test the tools to demonstrate feasibility as well as examine preliminary efficacy of the nudges on provider adoption of the tool. This cluster non-randomized controlled trial took place between September 20th, 2021 and March 3rd, 2022 in two EDs that are a part of a large academic health system in the New York City metropolitan area. All ED providers (physicians, physician assistants and nurse practitioners) seeing patients for the evaluation of PE during this time were included in the trial. The EDs were chosen based on their comparable size and acuity levels.

Interventions

OTHERPulmonary Embolism Risk Kalculator (PERK)

Nudges are applications of behavioral science, defined as positive reinforcement and indirect suggestions that have a non-forced effect on decision making. Nudges will be to the PE CALC CDS tool to develop the new CDS tool, PERK.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Medical doctors, nurse practitioners and physician assistants working full time at Huntington Hospital and Long Island Jewish Valley Stream

Exclusion criteria

* Does not meet the inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Patient Visits Where the Provider Adopted the Pulmonary Embolism Risk Kalculator (PERK) ToolUp to Month 6The tool is considered adopted during a patient visit if the provider accepted the recommendation given by the PERK tool (i.e., a D-dimer was recommended and ordered or a CT pulmonary angiogram (CTPA) was recommended and ordered). This outcome measure is assessed using electronic health record (EHR) data from the patient visit.

Secondary

MeasureTime frameDescription
Percentage of PE-Designated CTPA Tests That Are Positive for PEUp to Month 6Monitored using EHR reporting data. Calculated as the percentage of CTPA tests ordered to evaluate for PE that are positive for PE.

Countries

United States

Participant flow

Participants by arm

ArmCount
Intervention Site - Providers
Providers at the site assigned to the intervention: Full time employed Emergency Department providers will use the new CDS tool, Pulmonary Embolism Risk Kalculator (PERK), which includes nudges to improve use and will be integrated into the electronic medical record and will be accessible for 6 months Pulmonary Embolism Risk Kalculator (PERK): Nudges are applications of behavioral science, defined as positive reinforcement and indirect suggestions that have a non-forced effect on decision making. Nudges will be to the PE CALC CDS tool to develop the new CDS tool, PERK.
49
No Intervention Site - Providers
Providers at the site assigned to no intervention: Full time employed Emergency Department providers used a CDS tool, Pulmonary Embolism Calculator (PE CALC), without nudges to improve use, to reduce unnecessary imaging in the diagnosis of pulmonary embolism (PE) in the emergency department (ED).
35
Intervention Site - Patients
Patients at the site assigned to the intervention: Full time employed Emergency Department providers will use the new CDS tool, Pulmonary Embolism Risk Kalculator (PERK), which includes nudges to improve use and will be integrated into the electronic medical record and will be accessible for 6 months Pulmonary Embolism Risk Kalculator (PERK): Nudges are applications of behavioral science, defined as positive reinforcement and indirect suggestions that have a non-forced effect on decision making. Nudges will be to the PE CALC CDS tool to develop the new CDS tool, PERK.
793
No Intervention Site - Patients
Patients at the site assigned to no intervention: Full time employed Emergency Department providers used a CDS tool, Pulmonary Embolism Calculator (PE CALC), without nudges to improve use, to reduce unnecessary imaging in the diagnosis of pulmonary embolism (PE) in the emergency department (ED).
735
Total1,612

Baseline characteristics

CharacteristicIntervention Site - ProvidersNo Intervention Site - ProvidersIntervention Site - PatientsNo Intervention Site - PatientsTotal
Age, Continuous38 years35 years65 years64 years51 years
Ethnicity (NIH/OMB)
Hispanic or Latino
69 Participants32 Participants101 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
673 Participants617 Participants1290 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
51 Participants86 Participants137 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
14 Participants32 Participants46 Participants
Race (NIH/OMB)
Black or African American
42 Participants435 Participants477 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
119 Participants122 Participants241 Participants
Race (NIH/OMB)
White
618 Participants146 Participants764 Participants
Region of Enrollment
United States
49 Participants35 Participants793 Participants735 Participants1612 Participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 7930 / 735
other
Total, other adverse events
0 / 7930 / 735
serious
Total, serious adverse events
0 / 7930 / 735

Outcome results

Primary

Percentage of Patient Visits Where the Provider Adopted the Pulmonary Embolism Risk Kalculator (PERK) Tool

The tool is considered adopted during a patient visit if the provider accepted the recommendation given by the PERK tool (i.e., a D-dimer was recommended and ordered or a CT pulmonary angiogram (CTPA) was recommended and ordered). This outcome measure is assessed using electronic health record (EHR) data from the patient visit.

Time frame: Up to Month 6

ArmMeasureValue (NUMBER)
Intervention Site - Patients and ProvidersPercentage of Patient Visits Where the Provider Adopted the Pulmonary Embolism Risk Kalculator (PERK) Tool39.11 Percentage of Patient Visits
No Intervention Site - Patients and ProvidersPercentage of Patient Visits Where the Provider Adopted the Pulmonary Embolism Risk Kalculator (PERK) Tool20.66 Percentage of Patient Visits
Secondary

Percentage of PE-Designated CTPA Tests That Are Positive for PE

Monitored using EHR reporting data. Calculated as the percentage of CTPA tests ordered to evaluate for PE that are positive for PE.

Time frame: Up to Month 6

ArmMeasureValue (NUMBER)
Intervention Site - Patients and ProvidersPercentage of PE-Designated CTPA Tests That Are Positive for PE26.45 Percentage of PE-Designated CTPA Tests
No Intervention Site - Patients and ProvidersPercentage of PE-Designated CTPA Tests That Are Positive for PE10.76 Percentage of PE-Designated CTPA Tests

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026